Both peptides enhance GH production, tesamorelins effects on fat loss are more pronounced, while sermorelin offers broader therapeutic use with fewer regulatory restrictions
It is secreted by I-cells in the duodenal and small bowel mucosa in response to protein and fat, with its main effects on the liver, gallbladder, pancreas and, interestingly, central nervous system (CNS)
This includes addressing aspects like stomach acid production, esophageal health, the tone of the Lower Esophageal Sphincter (LES), and nutrient deficiencies
An alternative administration area is chosen based on provider assessment and patient comfort
These two work together to boost the bodys levels of growth hormone